Neuromidin solution 15mg / ml, No. 10

diseases of the peripheral nervous system (mono- and polyneuropathy, polyradiculopathy, myasthenia gravis and myasthenic syndrome of various etiologies);

diseases of the central nervous system (bulbar paralysis and paresis; the recovery period of organic lesions of the central nervous system, accompanied by motor and / or cognitive impairment);

intestinal atony (treatment and prevention) (optional for tablets).

Inside, s / c or i / m. Doses and duration of treatment are determined individually, depending on the severity of the disease.

Pills

Diseases of the peripheral nervous system:

- mono- and polyneuropathy, polyradiculopathy, myasthenia gravis and myasthenic syndrome of various etiology - 10-20 mg (0.5-1 table) 1-3 times a day. The course of treatment is 1 to 2 months. If necessary, the course of treatment can be repeated several times with a break between courses of 1-2 months;

- to prevent myasthenic crises, in severe disorders of neuromuscular conduction, 1-2 ml (15-30 mg) of NeuromidinЃ 1.5% solution for injection is briefly parenterally injected, then treatment is continued with NeuromidinЃ tablets, the dose can be increased to 20-40 mg (table 1-2) 5 times a day.

Diseases of the central nervous system: bulbar paralysis and paresis, the recovery period of organic lesions of the central nervous system (traumatic, vascular and other genesis), accompanied by motor and / or cognitive impairments - 10-20 mg (0.5-1 table) 2-3 times day. The course of treatment is from 2 to 6 months. If necessary, repeat the course of treatment.

Treatment and prevention of intestinal atony - 20 mg (1 tab.) 2-3 times a day for 1-2 weeks.

Solution for intramuscular and subcutaneous administration

Diseases of the peripheral nervous system:

- mono- and polyneuropathy of various origins - s / c or i / m 5-15 mg 1-2 times a day, course - 10-15 days (in severe cases - up to 30 days); further treatment is continued with a tablet form of the drug;

- myasthenia gravis and myasthenic syndrome - s / c or i / m 15-30 mg 1-3 times a day with a further transition to the tablet form. The general course of treatment is 1-2 months. If necessary, the treatment can be repeated several times with a break between courses of 1-2 months.

Diseases of the central nervous system:

- bulbar paralysis and paresis - s / c or i / m 5-15 mg 1-2 times a day for 10-15 days; if possible, switch to a tablet form;

- rehabilitation for organic lesions of the central nervous system - i / m 10-15 mg 1-2 times a day, the course - up to 15 days, then, if possible, switch to the tablet form.

If the next dose was not taken on time, then it is not taken additionally.

The maximum daily dose is 200 mg.

hypersensitivity to any component of the drug;

epilepsy;

extrapyramidal diseases with hyperkinesis;

angina pectoris;

severe bradycardia;

bronchial asthma;

mechanical obstruction of the intestine or urinary tract;

vestibular disorders;

peptic ulcer of the stomach or duodenum in the acute stage;

pregnancy (the drug increases the tone of the uterus);

lactation period;

children under 18 years of age (there are no systematized data on the use).

With care: in case of gastric ulcer and duodenal ulcer, thyrotoxicosis, CVS diseases, as well as in patients with a history of obstructive respiratory system diseases or in acute respiratory tract diseases.

Additionally for tablets

With caution: with lactase deficiency, lactose intolerance, lactose / isomaltose malabsorption syndrome, because the preparation contains lactose.